Navigation Links
TIBCO Spotfire and Integromics Partner on Development of Genomics Platform for Province of Andalusia

Spanish and Andalusia Government build infrastructure, education and

awareness for Life Sciences in Southern Spain

SOMERVILLE, Mass., Feb. 19 /PRNewswire-FirstCall/ -- Spotfire, a division of TIBCO Software Inc. (Nasdaq: TIBX), today announced that the company is joining forces for the development of a genomics platform for the Region of Andalusia in Spain. Integromics, a provider of state-of-the-art software solutions for data management and data analysis in Genomics, Proteomics and Drug Discovery, has been selected to create the platform, which is funded by the Governments of Spain and Andalusia, in efforts to build support for Life Science practices throughout southern Spain. The University of Malaga and the University of Cordoba will be responsible for the coordination of the platform.

Integromics will use TIBCO Spotfire's suite of products to create the Province's genomics platform, an open environment that integrates complex information and applications. Researchers and scientists located at universities, hospitals, and laboratories will have a direct, interactive, visual approach to data analysis that rapidly reveals insights and unexpected relationships. This helps to accelerate breakthroughs in potential disease treatments through collaboration and data sharing with participating groups throughout southern Spain, resulting in faster decision-making processes throughout their organizations.

"We are excited to be implementing the TIBCO Spotfire solution as a central resource for our Life Sciences labs in Andalusia. This technology will play a key role in integrating heterogeneous sources of information and creating easy-to-follow analytic guides for Genomics and Transcriptomics," said Dr. Guillermo Perez, spokesman and coordinator of IT systems of Plataforma Bioinformatica de Andalusia. "Working with leading companies like TIBCO Spotfire and Integromics to create a visual, interactive analytic application platform allows us to take a great step forward in providing end- users with the capability of running powerful analysis on their own."

"Spotfire has become the de facto standard enterprise analytics platform in the life sciences industry," said Dr. Vicente Rodriguez Carro, CEO of Integromics. "Integromics partnered with Spotfire to extend our services portfolio with a visual, interactive analytic application platform that easily integrates multiple data sources, and transforms data into an interactive decision-making asset. With this functionality, life science researchers can ask and answer new questions and create an advanced problem solving environment."

Unlike current first generation BI systems, the TIBCO Spotfire Enterprise Analytics platform is dramatically more adaptable to multiple industries and business processes. The TIBCO Spotfire platform enables Integromics' pharmaceutical, biotechnology, and academic research groups to quickly find and categorize complex patterns. With interactive analysis and high-impact visualization capabilities, users can examine the expression and annotation dimensions of their data and perform a variety of numerical analyses. Users can also collaborate across and outside their enterprises, providing interactive presentations of complex information.

"Creating knowledge from mass data is one of the most challenging issues facing research groups in the Life Sciences industry," said Christian Marcazzo, Senior Director of Life Science Analytics for Spotfire. "We're excited to be a part of a project that will provide researchers with a powerful environment to accelerate discovery by providing accurate, up-to-date analytics from a single reliable source."

About Integromics

Integromics S.L. provides state-of-the-art software solutions for data management and data analysis in Genomics, Proteomics and Drug Discovery. From its scientific base, Integromics offers its clients a deep and current understanding of challenges, initiatives and solutions related to Life Sciences. Integromics has formed important partnerships in industry and academia to develop technological solutions that enable clients to achieve their goals.

Integromics is headquartered at the Business Entreprenuer Facilities for Life Sciences (Parque Tecnologico de Ciencias de la Salud) of Granada, Spain. More information at:

About Spotfire

Spotfire, a division of TIBCO Software Inc., is a leading provider of enterprise analytics software for next generation business intelligence. Spotfire offers a visual and interactive experience that helps professionals quickly discover new and actionable insights in information. Distinguished by its speed to insight and adaptability to specific business challenges, Spotfire rapidly reveals unseen threats and new opportunities, creating significant economic value. Spotfire customers include industry leaders among the Global 2000 that have deployed Spotfire analytics to gain an information advantage over their competitors. For more information, visit

TIBCO, TIBCO Software, and Spotfire are trademarks or registered trademarks of TIBCO Software Inc. in the United States and/or other countries. All other product and company names and marks mentioned in this document are the property of their respective owners and are mentioned for identification purposes only.

Legal Notice Regarding Forward-Looking Statements

This release contains forward-looking statements within the meaning of the "safe harbor" provisions of the federal securities laws. All statements other than statements of historical fact could be deemed forward-looking, including statements regarding the future release of client and server application programming interfaces to support custom application development, "mash-ups" and other business process integrations. Because these forward-looking statements involve risks and uncertainties, important factors could cause actual results to differ materially. These factors include: any unforeseen technical difficulties or changes in technology and standards relating to the development of these new interfaces. Additional information regarding potential risks is provided in TIBCO's filings with the SEC, including its most recent Annual Report on Form 10-K for the year ended November 30, 2006 and Quarterly Report on Form 10-Q for the quarter ended March 4, 2007. TIBCO assumes no obligation to update the forward-looking statements included in this release.


Jim Baptiste Amy Groden-Morrison

Davies Murphy Group, Inc. TIBCO Spotfire Division

(781) 418-2438 (617) 702-1710

SOURCE TIBCO Software Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
2. AspenBio Pharma to Present at the Roth Capital Partners 20th Annual Growth Stock Conference
3. CryoLife to Present at Roth Capital Partners 20th Annual Orange County (OC) Growth Stock Conference
4. Biomoda and Medical Acoustics Partner in Study for Early Detection of Lung Cancer in Veterans
5. WaferGen to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
6. Ardea Biosciences to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
7. Gerson Lehrman Group Announces Partnership With BIO to Provide Scientific Expertise for the BIO CEO & Investor Conference
8. Oncology Metrics and E-Expert Reimbursement Partners Announce Joint Marketing and Product Development Agreement
9. Quintiles Completes Previously Announced New Investor Partnership, Co-Led by Founder, Chairman and CEO Dennis Gillings, Bain Capital, TPG and 3i
10. Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
11. Stereotaxis Announces FDA Approval of Its Partnered Magnetic Irrigated Catheter
Post Your Comments:
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... of medical marijuana products targeting the needs of consumers who are incorporating medical ... takes place in Phoenix, Arizona. , As operators of two successful Valley dispensaries, ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first ... accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution using their own ...
Breaking Biology Technology:
(Date:8/15/2017)... HAMPTON, Va. , Aug. 15 2017   ivWatch LLC ... effectiveness of intravenous (IV) therapy, today announced receipt of its ISO ... (QMS) developed by the International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for ... "This ...
(Date:5/23/2017)...  Hunova, the first robotic gym for the rehabilitation and functional motor ... Genoa, Italy . The first 30 robots will be ... USA . The technology was developed and patented at the ... spin-off Movendo Technology thanks to a 10 million euro investment from entrepreneur ... ...
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
Breaking Biology News(10 mins):